Patents by Inventor Michael Olausson

Michael Olausson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220183272
    Abstract: A method for recovering an organ harvested from a donor, wherein the organ has been retrieved at least two hours after the donor had circulation arrest, comprising the steps of providing lys-plasminogen to the organ in a first hyperoncotic fluid, followed by tPA in a second hyperoncotic fluid. A third hyperoncotic fluid comprising albumin and electrolytes is circulated through the organ in a first restoration step, and in a second restoration step, a fourth hyperoncotic fluid comprising oxygenated red blood cells is circulated through the organ. Then, the organ is evaluated by conventional criteria. A device and a fluid for use in the method is also disclosed.
    Type: Application
    Filed: April 12, 2020
    Publication date: June 16, 2022
    Applicant: UGLX RESEARCH AB
    Inventor: Michael OLAUSSON
  • Publication number: 20220183273
    Abstract: Method and device and fluid for recovering a harvested kidney, for example from a cardiac arrest carcass, wherein the kidney has been exposed to warm ischemia during 4 hours or more. At the backtable after harvesting, there is injected lys-plasminogen to the kidney and after 15 minutes, t-PA is injected. A hyperoncotic circulation fluid comprising albumin and electrolytes is added and circulated through the kidney together with said lys-plasminogen and t-PA, whereby the circulation pressure is increased from 20 mmHg to 70 mmHg during 30 to 75 minutes, for example in steps of 5 mmHg per 5 minutes. Then, the kidney is evaluated by conventional criteria.
    Type: Application
    Filed: April 12, 2020
    Publication date: June 16, 2022
    Applicant: UGLK SCIENCE AB
    Inventor: Michael OLAUSSON
  • Publication number: 20200147272
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: December 27, 2019
    Publication date: May 14, 2020
    Applicant: VeriGraft AB
    Inventors: Suchitra SUMITRAN-HOLGERSSON, Michael OLAUSSON
  • Patent number: 10517996
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: December 31, 2019
    Assignee: Verigraft AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Publication number: 20180055973
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: April 7, 2017
    Publication date: March 1, 2018
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Patent number: 9662421
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: May 30, 2017
    Assignee: NOV AHEP AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Publication number: 20170049935
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: June 1, 2016
    Publication date: February 23, 2017
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Patent number: 9433706
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: September 6, 2016
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Publication number: 20160045642
    Abstract: The present invention relates to methods for recellurization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: May 28, 2015
    Publication date: February 18, 2016
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Patent number: 9090879
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Grant
    Filed: March 1, 2013
    Date of Patent: July 28, 2015
    Assignee: NOVAHEP AB
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson
  • Publication number: 20140377864
    Abstract: The present invention relates to methods for recellularization of blood vessels. This method is particularly useful for producing an allogeneic vein, wherein a donor vein is decellularized and then recellularized using whole blood or bone marrow stem cells. The allogeneic veins produced by the methods disclosed herein are particularly advantageous for implantation or transplantation into patients with vascular diseases.
    Type: Application
    Filed: March 1, 2013
    Publication date: December 25, 2014
    Inventors: Suchitra Sumitran-Holgersson, Michael Olausson